And its neuroprotective effect has become a research hotspot in recent years
n = 35 Glp1r / mice/group
Their use is rising rapidly, and with good reason: These medications have been shown to reduce blood sugar, improve fatty liver, GERD, sleep apnea, osteoarthritis, blood pressure, triglycerides, major adverse cardiovascular events, and even show potential benefits for conditions like alcohol use disorder (Mozaffarian et al., 2025
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity in Diabetes: from Research to Clinical Practice: Volume 4 (ed
The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study
Semaglutide as Ozempic and liraglutide as Victoza are licensed for type 2 diabetes management, while semaglutide as Wegovy and liraglutide as Saxenda are specifically licensed for weight management